T-CELL MALIGNANCIES
Clinical trials for T-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new T-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for T-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough T-Cell cancers in new trial
Disease control Recruiting nowThis study tests a new treatment called CD5-CAR T cell therapy for people with T-cell cancers that have come back or not responded to standard treatments. The therapy uses a patient's own or a donor's immune cells, modified to target and kill cancer cells. The trial will first fi…
Matched conditions: T-CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis study tests a new treatment called CD5 CAR T cells for people with T-cell blood cancers that have come back or not responded to standard therapy. About 54 participants will receive specially engineered immune cells designed to find and attack cancer cells. The goal is to che…
Matched conditions: T-CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Engineered immune cells take on tough T-Cell cancers
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CD7 CAR T-cells) for people with T-cell cancers that have come back or not responded to standard therapy. The cells are made from the patient's own blood or from a donor. The goal is to check safety first, …
Matched conditions: T-CELL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC